Consequences of disclosing clinical trial results: Evidence from the food and drug administration amendments act
We examine how the U.S. Food and Drug Administration Amendments Act (FDAAA) of 2007, which requires additional disclosures regarding clinical trial results, impacts information asymmetry between the disclosing pharmaceutical firm and capital market participants, the general public, academics, and pr...
Saved in:
| Main Authors: | , , |
|---|---|
| 格式: | text |
| 語言: | English |
| 出版: |
Institutional Knowledge at Singapore Management University
2020
|
| 主題: | |
| 在線閱讀: | https://ink.library.smu.edu.sg/soa_research/1838 https://ink.library.smu.edu.sg/context/soa_research/article/2865/viewcontent/SSRN_id3533305.pdf |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
| 機構: | Singapore Management University |
| 語言: | English |